Main Pancreatic Duct Dilatation: a Sign of High Risk for Pancreatic Cancer
The DOI matches its Crossref record.
Abstract
BACKGROUND: The prognosis of pancreatic ductal adenocarcinoma remains very poor, but is better in patients with a small tumor without local infiltration. The identification of the sign of high risk for pancreatic cancer will lead to early detection and improvement of the prognosis of this disease. The purpose of this study was to evaluate the main pancreatic duct dilatation as a sign of high risk for pancreatic cancer. METHODS: The diameter of the main pancreatic duct was measured by ultrasonography. The proportion of cases with main pancreatic duct dilatation was retrospectively examined in a pre-cancer group (39 subjects in whom pancreatic cancer developed more than 1 year later and surgically resected) and in a control group (10 244 subjects). Then the proportions in both groups were compared using the odds ratio. RESULTS: The proportion of cases with a slight dilatation (>/=2 mm in diameter) of the main pancreatic duct was 65% in the pre-cancer group, more than 4 years before the resection of the pancreatic cancer. In contrast, it was 5.35% in the age-matched control subjects. The odds ratio of 32.5 (95% confidence interval: 10.9-107.3) shows a significant association between the main pancreatic duct dilatation and the pre-cancer condition. Moreover, the proportion and the mean diameter of the dilated duct in the pre-cancer group increased with time. CONCLUSION: Slight dilatation of the main pancreatic duct appears to be a sign of high risk for pancreatic cancer. The systematic examination of high-risk subjects is recommended for the early detection of pancreatic cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Yoon, S. H., Lee, J. M., Cho, J. Y., Lee, K. B., Kim, J. E., Moon, S. K., Kim, S. J., Baek, J. H., Kim, S. H., Kim, S. H., et al. (2011) · Radiology · doi:10.1148/radiol.11101133 · Cited by 257
Gangi, S., Fletcher, J. G., Nathan, M. A., Christensen, J. A., Harmsen, W. S., Crownhart, B. S., & Chari, S. T. (2004) · American Journal of Roentgenology · doi:10.2214/ajr.182.4.1820897 · Cited by 249
Indicative findings of pancreatic cancer in prediagnostic CT
Ahn, S. S., Kim, M.-J., Choi, J.-Y., Hong, H.-S., Chung, Y. E., & Lim, J. S. (2009) · European Radiology · doi:10.1007/s00330-009-1422-6 · Cited by 105
“[15] also reported that main pancreatic duct dilation was detected in 65% of cancer patients several years before pancreatic cancer resection.”
Factors associated with missed and misinterpreted cases of pancreatic ductal adenocarcinoma
Kang, J. D., Clarke, S. E., & Costa, A. F. (2021) · European Radiology · doi:10.1007/s00330-020-07307-5 · Cited by 84
Qureshi, T. A., Gaddam, S., Wachsman, A. M., Wang, L., Azab, L., Asadpour, V., Chen, W., Xie, Y., Wu, B., Pandol, S. J., et al. (2022) · Cancer Biomarkers · doi:10.3233/cbm-210273 · Cited by 79
Metadata
- Authors
- Tanaka, S.
- Venue
- Japanese Journal of Clinical Oncology
- Publisher
- Oxford University Press (OUP)
- Published
- 2002-10-01
- Volume
- 32
- Issue
- 10
- Pages
- 407-411
- ISSN
- 0368-2811 (ISSN-L)
- 1465-3621
- OpenAlex
- W2145872640
- Cited by
- 103
- References
- 0
- FWCI
- 1.10
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Main Pancreatic Duct Dilatation: a Sign of High Risk for Pancreatic Cancer. https://app.cochat.ai/papers/10.1093/jjco/hyf093
- The paper
- Tanaka, S. (2002). Main Pancreatic Duct Dilatation: a Sign of High Risk for Pancreatic Cancer. Japanese Journal of Clinical Oncology. https://doi.org/10.1093/jjco/hyf093
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.